Synovial perfusion and synovial fluid solutes.
作者信息
Simkin P A
机构信息
Department of Medicine, University of Washington, Seattle 98195, USA.
出版信息
Ann Rheum Dis. 1995 May;54(5):424-8. doi: 10.1136/ard.54.5.424.
Abstract
摘要
相似文献
1
Synovial perfusion and synovial fluid solutes.滑膜灌注与滑液溶质
Ann Rheum Dis. 1995 May;54(5):424-8. doi: 10.1136/ard.54.5.424.
2
3
Concentration-effect relationships of NSAID.非甾体抗炎药的浓度-效应关系。
J Rheumatol Suppl. 1988 Oct;17:40-3.
4
Synovial perfusion of clinically normal knee joints in patients with rheumatoid arthritis. An isotope study.类风湿关节炎患者临床正常膝关节的滑膜灌注。一项同位素研究。
Ann Rheum Dis. 1970 Nov;29(6):649-52. doi: 10.1136/ard.29.6.649.
5
Selected aspects of synovial membrane physiology.滑膜生理学的选定方面。
Arthritis Rheum. 1974 May-Jun;17(3):289-96. doi: 10.1002/art.1780170314.
6
Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.类风湿性关节炎患者中水杨酸盐与滑液和血浆蛋白结合的特征分析。
Eur J Clin Pharmacol. 1980 Nov;18(5):403-6. doi: 10.1007/BF00636793.
7
Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.吡罗昔康与类风湿关节炎患者滑液及血浆蛋白的结合情况。
Eur J Clin Pharmacol. 1984;26(4):457-61. doi: 10.1007/BF00542141.
8
Correlation between synovial blood flow signals and serum vascular endothelial growth factor levels in patients with refractory rheumatoid arthritis.难治性类风湿关节炎患者滑膜血流信号与血清血管内皮生长因子水平的相关性
Mod Rheumatol. 2009;19(2):187-91. doi: 10.1007/s10165-008-0146-9. Epub 2009 Feb 17.
9
Partial purification and characterisation of a synovial fluid inhibitor of osteoblasts.成骨细胞滑膜液抑制剂的部分纯化与特性分析
Ann Rheum Dis. 1990 Feb;49(2):121-4. doi: 10.1136/ard.49.2.121.
10
Hypoxia and inflammatory synovitis: observations and speculation.缺氧与炎性滑膜炎：观察与推测
Ann Rheum Dis. 1991 Feb;50(2):124-32. doi: 10.1136/ard.50.2.124.
引用本文的文献
1
Liposome-Based Interventions in Knee Osteoarthritis.基于脂质体的膝关节骨关节炎干预措施
Small. 2025 Apr;21(17):e2410060. doi: 10.1002/smll.202410060. Epub 2025 Mar 27.
2
Kinetics and Retention of Polystyrenesulfonate for Proteoglycan Replacement in Cartilage.聚磺苯乙烯用于软骨蛋白聚糖替代的动力学和保留。
Biomacromolecules. 2024 Sep 9;25(9):5819-5833. doi: 10.1021/acs.biomac.4c00479. Epub 2024 Aug 14.
3
Review of the pharmacokinetics of French maritime pine bark extract (Pycnogenol) in humans.法国滨海松树皮提取物（碧萝芷）在人体中的药代动力学综述。
Front Nutr. 2024 May 2;11:1389422. doi: 10.3389/fnut.2024.1389422. eCollection 2024.
4
Lymphatic vessels: roles and potential therapeutic intervention in rheumatoid arthritis and osteoarthritis.淋巴管：类风湿关节炎和骨关节炎中的作用和潜在治疗干预。
Theranostics. 2024 Jan 1;14(1):265-282. doi: 10.7150/thno.90940. eCollection 2024.
5
Targeting Lymph Nodes for Systemic Immunosuppression Using Cell-Free-DNA-Scavenging And cGAS-Inhibiting Nanomedicine-In-Hydrogel for Rheumatoid Arthritis Immunotherapy.用无细胞 DNA 清除和 cGAS 抑制纳米药物在水凝胶中靶向淋巴结进行系统性免疫抑制治疗类风湿关节炎的免疫疗法。
Adv Sci (Weinh). 2023 Sep;10(26):e2302575. doi: 10.1002/advs.202302575. Epub 2023 Jul 12.
6
Targeting damaged collagen for intra-articular delivery of therapeutics using collagen hybridizing peptides.利用胶原杂交肽靶向损伤的胶原蛋白实现关节内递药。
J Orthop Res. 2023 Nov;41(11):2424-2432. doi: 10.1002/jor.25577. Epub 2023 May 2.
7
Gene therapy approaches for equine osteoarthritis.马骨关节炎的基因治疗方法。
Front Vet Sci. 2022 Sep 28;9:962898. doi: 10.3389/fvets.2022.962898. eCollection 2022.
8
Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility.专门用于减轻痛风炎症性疼痛的局部用产品测试：透皮非甾体抗炎药递送与尿酸钠溶解度
J Pain Res. 2022 Jun 29;15:1825-1835. doi: 10.2147/JPR.S367536. eCollection 2022.
9
Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage.通过纳米颗粒贮库将小干扰RNA递送至受损软骨来改善创伤后骨关节炎
Nat Biomed Eng. 2021 Sep;5(9):1069-1083. doi: 10.1038/s41551-021-00780-3. Epub 2021 Aug 19.
10
Top-Down Fabricated microPlates for Prolonged, Intra-articular Matrix Metalloproteinase 13 siRNA Nanocarrier Delivery to Reduce Post-traumatic Osteoarthritis.用于延长关节内基质金属蛋白酶 13 siRNA 纳米载体递送的自上而下制造的微板，以减少创伤后骨关节炎。
ACS Nano. 2021 Sep 28;15(9):14475-14491. doi: 10.1021/acsnano.1c04005. Epub 2021 Aug 19.
本文引用的文献
1
Articular pharmacokinetics of protein-bound antirheumatic agents.蛋白结合型抗风湿药物的关节药代动力学。
Clin Pharmacokinet. 1993 Oct;25(4):342-50. doi: 10.2165/00003088-199325040-00007.
2
Cutaneous laser Doppler flowmetry: applications and findings.皮肤激光多普勒血流仪：应用与研究结果。
Mayo Clin Proc. 1994 Jun;69(6):564-74. doi: 10.1016/s0025-6196(12)62249-6.
3
Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions.
Clin Exp Rheumatol. 1994 Jan-Feb;12(1):55-8.
4
Effect of synovial fluid hyaluronan on the clearance of albumin from the canine knee.滑液透明质酸对犬膝关节白蛋白清除率的影响。
Ann Rheum Dis. 1995 May;54(5):433-4. doi: 10.1136/ard.54.5.433.
5
Functions of hyaluronan.透明质酸的功能。
Ann Rheum Dis. 1995 May;54(5):429-32. doi: 10.1136/ard.54.5.429.
6
Permeability of rheumatoid and normal human synovium to specific plasma proteins.类风湿性和正常人滑膜对特定血浆蛋白的通透性。
Arthritis Rheum. 1981 Dec;24(12):1550-60. doi: 10.1002/art.1780241215.
7
Relative error and variability in blood flow measurements with radiolabeled microspheres.
Am J Physiol. 1982 Sep;243(3):H371-8. doi: 10.1152/ajpheart.1982.243.3.H371.
8
Transynovial exchange of small molecules in normal human subjects.正常人体滑膜小分子的交换
J Appl Physiol. 1974 May;36(5):581-7. doi: 10.1152/jappl.1974.36.5.581.
9
Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.吲哚美辛在血清和滑液中的同步药代动力学。
Ann Rheum Dis. 1973 Sep;32(5):433-5. doi: 10.1136/ard.32.5.433.
10
Low synovial clearance of iodide provides evidence of hypoperfusion in chronic rheumatoid synovitis.碘化物的滑膜清除率低为慢性类风湿性滑膜炎灌注不足提供了证据。
Arthritis Rheum. 1985 Oct;28(10):1096-1104. doi: 10.1002/art.1780281004.
Zotero 插件